Key facts
- Eco-inject’s last known valuation is $21.1M (Feb 2026).
- It has raised $7.1M; the latest was Early Stage VC ($7.1M) in Feb 2026.
- Notable investors include Adjuvo.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Eco-inject
- ·The full record, as it builds
Funding rounds
No funding rounds for Eco-inject are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Eco-inject
Developer of injection delivery devices designed for self-administration of injectable therapies with lower environmental impact. The company offers a customizable, single-use platform compatible with multiple pre-filled syringe formats and viscosities, featuring a reduced component count, a novel latch-and-release mechanism, simplified sub-assembly and final assembly, and support for bio-based plastics, enabling pharmaceutical manufacturers and drug-delivery specialists to improve manufacturing efficiency, lower unit and lifecycle costs, and decrease resource consumption and waste across the autoinjector value chain.
- Sector
- Healthcare
- HQ
- Cambridge, United Kingdom
- Founded
- 2023
- Employees
- 5
- Website
- eco-inject.com/
- Ownership
- Privately Held (backing)
Eco-inject doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Eco-inject shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Eco-inject in its N-PORT filings yet. We sweep new filings monthly.